Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
30M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
295K
-
Shares change
-
-294K
-
Total reported value, excl. options
-
$1.81M
-
Value change
-
-$1.82M
-
Number of buys
-
5
-
Number of sells
-
-9
-
Price
-
$6.12
Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q4 2020
18 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share as of Q4 2020.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 295K shares
of 30M outstanding shares and own 0.98% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (118K shares), BlackRock Inc. (80.6K shares), GEODE CAPITAL MANAGEMENT, LLC (31.1K shares), Strategic Wealth Designers (15.2K shares), NATIXIS (15K shares), NORTHERN TRUST CORP (11.2K shares), Atom Investors LP (11K shares), Virtu Financial LLC (10.5K shares), SIMPLEX TRADING, LLC (1.74K shares), and MORGAN STANLEY (280 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.